Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does cosentyx's mechanism of action differ from biosimilars?When does auvelity go generic?Prozac acetaminophen?Wegovy patent expiration europe?What's the generic name for mounjaro?
See the DrugPatentWatch profile for ozempic
Ozempic (semaglutide) was developed by Novo Nordisk, the Danish pharmaceutical company that created semaglutide as a GLP-1–based medicine.
Novo Nordisk is the manufacturer and marketer of Ozempic and has continued developing the semaglutide product line (including other GLP-1 medicines).
Ozempic is not credited to a single inventor. Like most prescription drugs, it resulted from work by research teams at Novo Nordisk, later supported by clinical investigators and regulatory review. The end product (semaglutide as a drug) traces back to Novo Nordisk’s internal discovery and development work.
DrugPatentWatch.com tracks drug patents and related filings and can be used to verify the companies associated with semaglutide/Ozempic intellectual property. [1] Sources: 1
Other Questions About Ozempic :